Tesamorelin 5mg

Tesamorelin is a growth hormone–releasing hormone (GHRH) analogue used in controlled in-vitro studies of GHRH receptor signalling, cAMP/PKA pathways, and GH-axis models under non-clinical laboratory conditions.

Tesamorelin — 5 mg

This peptide is a stabilised analogue of human GHRH(1–44). Consequently, laboratories select it to explore ligand–receptor engagement, downstream second-messenger responses, and assay readouts relevant to somatotropic signalling in model systems.
For laboratory research only. Not for human use.

Tesamorelin Key features

• GHRH analogue for in-vitro studies of GHRHR signalling and GH-axis biology.
• Supplied as a lyophilised solid for stability and straightforward storage.
• Unit size: 5 mg per vial.
• Each batch released only after stringent quality checks.

Specifications

• Product name: Tesamorelin
• Synonyms: TH9507; GHRH(1–44) analogue
• Class: Peptide analogue of growth hormone–releasing hormone
• Form: Lyophilised powder
• Appearance: White to off-white solid
• Note: Exact properties may vary by counterion/hydration state.

Handling & storage

1. Storage (dry): Keep vials protected from light and moisture.
2. Reconstitution: Bring vial and diluent to room temperature. Reconstitute with
   Bacteriostatic Water 10 ml. Swirl gently — do not vortex.
3. After reconstitution: Store at 2–8 °C, protect from light, use aliquots to reduce handling, and avoid repeated temperature cycling.
4. Compatibility: Use only within research protocols that follow your lab’s SOPs and local regulations.